Quick Answer
COSCIENS Biopharma Inc. reported Gross Profit of $2.65 million for the year ending 2025.
- COSCIENS Biopharma Inc. showed a decrease of -44.0% in Gross Profit from 2024 to 2025.
- This data is from COSCIENS Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2016 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2016 to 2025), COSCIENS Biopharma Inc.'s Gross Profit has grown by 190.6%.
- Historical annual values: Fiscal year 2025: $2.65 million | Fiscal year 2024: $4.73 million | Fiscal year 2023: $2.94 million | Fiscal year 2022: $11.02 million | Fiscal year 2018: $24.78 million | Fiscal year 2017: $923.0 thousand | Fiscal year 2016: $911.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: